RT Journal Article
SR Electronic
T1 Mortality due to SARS COV-2 And its Associated Factors in East Shewa Zone Treatment Centers, Ethiopia, 2022: A retrospective cross-sectional study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.11.28.22282830
DO 10.1101/2022.11.28.22282830
A1 Hassen, Jemal
A1 Getinet, Tewodros
A1 Botore, Abera
A1 Bekele, Mesfin
A1 Bekele, Bayissa
A1 Jalata, Firaol
A1 Abebe, Wake
A1 Sisay, Mekdes
A1 Getahun, Asnakech
A1 Ligidi, Tadesse
YR 2022
UL http://medrxiv.org/content/early/2022/11/29/2022.11.28.22282830.abstract
AB Background Coronavirus disease (COVID-19) is an infectious disease that is caused by the SARS-CoV-2virus. The objective of this study was to determine SARS COV-2 Mortality and its associated factors in East Shewa Zone Treatment centers, Oromia, Ethiopia, 2022. The study of these types of viral infection will add new insight into the most common causes of mortality in SARS-CoV-2infection and the most common co-morbidities associated with the disease in the East Shewa Zone.Methods The study was conducted on patients who were admitted to Adama Hospital medical college and Modjo Primary Hospital for SARS-COV 2 treatment. Data used for the study were collected from March 2020-April 2022 GC. The study population was SARS-COV 2 patients who come to Adama Hospital and Medical College and Modjo Primary Hospital for treatment. All eligible SARS-CoV-2 patients’ data were collected from Both Adama and Modjo treatment center SARS-CoV-2 accession registration book and medical record card.Result A total of 409 patient data were collected from which 199 were from Adama Hospital and Medical College and 210 samples were collected from Modjo Primary Hospital Treatment center. The study design was a retrospective Cross-sectional study. The most affected age group in terms of mortality was the age group between 60-69 years old which suffers a 45.28% death rate. The major sign symptoms identified include cough (80.4%), Shortness of breath (66.7%) followed by fever (43.2%). SARS-CoV-2 Comorbidity was detected in 152 (37.2%) patients. Pneumonia was identified as the major comorbid disease to be recorded with 89(21.8%) cases. Other major comorbidities include Hypertension (16.9%) and Diabetes Mellites (13.9%). The least identified comorbidities were anemia (0.2%), Rectal cancer (0.2%), breast cancer (0.5%), and Chronic liver disease.Conclusion Nearly one in four (22.7%) SARS-COV 2 patients admitted for treatment to Adama Hospital and Medical College and Modjo Primary Hospital did not make their way out of treatment Hospitals alive. Pneumonia was identified as the major comorbid disease to be recorded with 89(21.8%) casesCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by Adama Public Health Research and Referral Laboratory CenterAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approvals were waived by Oromia Regional Health bureau Health Research Ethical Committe. Ethical approval original local language protocol Number BFO/MOTFYH/1-16/100009I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData set used in this study are available upon request from editorial manager of other relevant body upon requestACAnticoagulantAHMCAdama Hospital Medical CollegeAKIAcute Kidney InjuryALPAlkaline phosphataseALTAlanine transaminaseAPHRRLCAdama Public Health Research and Referral laboratory CenterARDSAcute Respiratory Distress SyndromeASTAspartate AminotransferaseBSCBachelor of ScienceBUNBlood Urea NitrogenCaCalciumCACancerCDCCenter For Disease Control and Prevention, USACHFCardiac Heart FailureCLDChronic Liver DiseaseCLDChronic Liver DiseaseCNSCentral Nervous SystemCOPDChronic obstructive pulmonary diseaseCOVID 19Coronavirus 19CSACentral statistics Agency, EthiopiaCTcomputerized tomographyCVDCardio Vascular DiseaseCXRChest X rayDMDiabetes MellitusECEthiopian CalendarEPIINFOEpidemiological InformationHIVHuman Immuno deficiency VirusHTNHypertensionIBM SPSSInternational Business Machines, Statistical Package for Social SciencesICUIntensive Care UnitIQRInter quartile RangeIRBInstitutional review boardKPotassiumLOSLength of StayMPHMasters of Public HealthNaSodiumNYCNew York CityP VALUEProbability valueSARSCOV2 Severe Acute Respiratory Syndrome - Corona Virus - 2 sCr Serum CreatinineSGOTserum glutamic-oxaloacetic transaminaseSGPTSerum Glutamic Pyruvic TransaminaseSOBShortness of breathTBTuberculosisUHFUnfractionated HeparinUKUnited KingdomUSAUnited States of AmericaVBMVariant Being MonitoredVOCVariant of ConcernVOHSVariant of High ConsequenceVOIVariant of InterestWBCWhite Blood CellWHOWorld Health Organization